z-logo
open-access-imgOpen Access
Medication follow-up in newborns with extremely low birth-weight
Author(s) -
Catarine Vitor Loureiro,
Marta Maria de França Fonteles,
Mylenne Borges Jácome Mascarenhas,
Elana Figueiredo Chaves,
Paulo Yuri Milen Firmino
Publication year - 2019
Publication title -
pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 24
eISSN - 1886-3655
pISSN - 1885-642X
DOI - 10.18549/pharmpract.2019.4.1584
Subject(s) - pharmacotherapy , medicine , neonatal intensive care unit , pediatrics , birth weight , medical prescription , low birth weight , population , pregnancy , pharmacology , environmental health , biology , genetics
The research evidenced the role of the clinical pharmacist in the solution and prevention of drug-related problems, contributing with the multidisciplinary team to obtain a safe and effective pharmacotherapy. Further, current study confirmed that there is an association between the characteristics of the newborns under analysis (eg. birth-weight, pharmacotherapy) and the occurrence of drug-related problems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom